GSK Consumer Healthcare is slated to announce its 4QCY2012 results today.

Commenting on the expectations, Angel Broking said, ''We expect the topline to grow by 18.6% yoy to Rs 7.14 billion. OPM is expected to increase by 47 bp yoy to 10.7%. Bottom-line is expected to grow by 29.4% yoy to Rs 770 million. We maintain a 'Neutral' recommendation on the stock. ''

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.